Performance and Durability of Cryopreserved Allograft Aortic Valve Replacements
نویسندگان
چکیده
BackgroundThe value of allografts for aortic root replacement is controversial, with recent concern about limited durability. Currently, we prefer invasive infective endocarditis. Purposes this study were to assess allograft performance and durability in our cumulative experience allografts.MethodsFrom January 1987 2017, 2042 adults received 2110 replacements at institution: 986 (47%) endocarditis (669 [68%] prosthetic valve endocarditis) 1124 (53%) other indications. Mean recipient age was 54 ± 15 years, mean donor 35 13 years. Follow-up 85% complete comprised 17,253 patient-years data. Longitudinal extracted from 6339 available echocardiographic studies. Durability assessed by explant structural failure.ResultsAllograft gradient hospital discharge 6 mm Hg 9, 13, 5, 10, years post-implant, respectively. Severe regurgitation 0% discharge, but 14%, 25%, 35% A total 405 explanted failure, actuarially 2%, 34%, 51% 15, 20 Risk factors failure younger age, larger body surface area, hypertension, thoracic aorta disease; older size. Implant not associated accelerated failure.ConclusionsThis affirms allografts’ long-term acceptable hemodynamic Concern should limit use. Recipient size, are modifiable risk factors. The allografts. From failure. Allograft This
منابع مشابه
Primary aortic valve replacement with cryopreserved aortic allograft: an echocardiographic follow-up study of 570 patients.
BACKGROUND Despite the many advantages of an aortic allograft valve (AAV) over a prosthetic aortic valve, its durability is suboptimal. The aims of the present study were to document characteristic features of AAV dysfunction and to investigate factors influencing the development of such dysfunction. METHODS AND RESULTS A group of 570 patients (mean age, 48+/-16 years) with a cryopreserved AA...
متن کاملCryopreserved aortic homograft for aortic valve replacement: immediate results.
OBJECTIVE To assess immediate clinical and echocardiographic results of the use of cryopreserved aortic homografts for aortic valve replacement. METHODS Eighteen patients with aortic valve disease underwent aortic valve replacement, receiving a cryopreserved aortic homograft, 15 were male, 10 had aortic regurgitation, and 8 had aortic stenosis. Age ranged from 18 to 65 years (mean, 44.5 +/- 1...
متن کاملTranscatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements.
Transcatheter aortic valve implantation is increasingly being used to treat severe aortic stenosis in patients with high operative risk. In an aging population the incidence of aortic stenosis is rising, and increasing numbers of elderly patients are undergoing aortic valve replacement with bioprosthetic valves. Therefore, there is a corresponding increase in prosthetic degeneration. This prese...
متن کاملeComment. The current bioprosthesis of choice for aortic valve replacements.
ference in postoperative aortic valve area, maximum velocity across the valve and mortality. Pelletier et al. [8] performed a cohort study comparing 878 CE porcine and 715 Ionescu-Shiley, CE and Mitroflow bovine valves in AVR, MVR or MR from 1976–88. It showed similar late survival rates and clinical improvement. However, the freedom from all valve-related complications was significantly better...
متن کاملMidterm results of aortic valve replacement with cryopreserved homografts.
OBJECTIVE The aim of this study was to analyze the midterm clinical results of aortic valve replacement with cryopreserved homografts. MATERIALS AND METHODS Aortic valve replacement was performed in 40 patients with cryopreserved homograft. The indications were aortic valve endocarditis in 20 patients (50%), truncus arteriosus in 6 patients (15%), and re-stenosis or regurtitation after aortic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Annals of Thoracic Surgery
سال: 2021
ISSN: ['1552-6259', '0003-4975']
DOI: https://doi.org/10.1016/j.athoracsur.2020.07.033